UNSPSC 51451604: Oxfendazole

This classification denotes an antihelminthic agent with the molecular formula C15H13N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OMP2H17F9E, chemically known as 2-benzimidazolecarbamic acid, 5-(phenylsulfinyl)-, methyl ester but generally known as oxfendazole, which bears US NIH Compound Identifier 40854. European Medicines Agency schedules Oxfendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09519MIG.

UNSPSC 51451604 Oxfendazole is a Commodity code that appears to see little relevant recent state and local procurement activity. The recent opportunities tagged under this code do not align with the code's nominal scope—oxfendazole is an anthelmintic veterinary pharmaceutical, yet the state and local records show purchases of Doxycycline Hyclate, Ciprofloxacin Hydrochloride, Naloxone, and drug deactivation systems for human health applications. State and local governments do procure pharmaceuticals through piggyback contracts with established consortia and through competitive IFBs, but the specific products being solicited under this code number do not match its intended category.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract in August 2026 through the MMCAP Infuse consortium to Chartwell Rx LLC for antibiotic tablets totaling $2,999,999.11 over three years, while Seminole County, Florida issued an IFB in June 2026 for naloxone and drug deactivation systems with quarterly deliveries. These procurement vehicles—cooperative-purchasing piggybacks and county competitive bids—are standard for state and local pharmaceutical sourcing, but the code classification appears to be a data error rather than a signal of active oxfendazole demand. If your firm sources oxfendazole for veterinary applications, this code would not be a reliable indicator of state and local opportunity.